Primary Insider Notification | Gentian
medical, diagnostics, immunoassays, assays, in vitro diagnostics, IVD products, avian antibodies, antibodies, clinical chemistry, diagnostic tests, biotechnology
16346
post-template-default,single,single-post,postid-16346,single-format-standard,ajax_fade,page_not_loaded,,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-14.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.7,vc_responsive
 

Primary Insider Notification

Primary Insider Notification

Safrino AS, a company controlled by Bendik Sundrehagen who is member of the Board of Directors, has today sold 50,000 Shares in Gentian Diagnostics AS at a price of NOK 50 per share. Following the transaction, the total holding held by Safrino AS is 1,300,000 shares.

MeldingsID: 453768
UtstederID: GENT-ME
Instrument: GENT-ME
Marked: Merkur Market
Kategori: MELDEPLIKTIG HANDEL FOR PRIMÆRINNSIDERE
Informasjonspliktige opplysninger: Ja
Vedlegg: Primary insider notification Safrino AS (1)